malondialdehyde has been researched along with rifamycins in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bannister, JV; Bannister, WH; Cabedo, H; Iradi, A; Sáez, GT; Valls, V | 1 |
| Antonioli, L; Bartalucci, A; Blandizzi, C; Colucci, R; Flaibani, M; Fornai, M; Ghelardi, E; Natale, G; Pellegrini, C; Renzulli, C; Sacco, D; Scarpignato, C; Tirotta, E | 1 |
2 other study(ies) available for malondialdehyde and rifamycins
| Article | Year |
|---|---|
Effect of metal ion catalyzed oxidation of rifamycin SV on cell viability and metabolic performance of isolated rat hepatocytes.
Topics: Animals; Catalase; Cell Survival; Copper; Gluconeogenesis; Glutathione; Iron; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oxidation-Reduction; Oxygen Consumption; Rats; Rats, Inbred Strains; Rifamycins; Thiobarbiturates | 1991 |
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; DNA, Bacterial; Firmicutes; Ileum; Indomethacin; Intestinal Absorption; Intestinal Diseases; Jejunum; Male; Malondialdehyde; Peroxidase; Proteobacteria; Rats, Wistar; Rifamycins; Rifaximin; Tumor Necrosis Factor-alpha | 2016 |